01 January 2008
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. RegazziAnn Transplant 2008; 13(1): 42-42 :: ID: 880208
Abstract
Background: Long-term therapy with MMF may induce IMPDH activity in peripheral blood mononuclear cells (MNC), reducing its immunosuppressive properties.
Material/Methods: IMPDH activity was measured in MNCs samples from 73 stable kidney transplant patients (median treatment time: 34 months, range: 3-75), before (t0) and 2 hours after (t2) MMF administration and monitored for up to 12 months. MMF treatment was combined with cyclosporine (CsA group) in 24 subjects, tacrolimus (TAC group) in 33, and sirolimus (SRL group) in 16. Samples from 95 healthy subjects were used as controls.
Results: IMPDH activity in healthy subjects was highly variable, mean 8.33±6.93 nmol/h/mg, with no relevant association with sex or age. In transplant recipients, during 12 months of MMF therapy, t0 IMPDH activity increased from 5.5±3.93 to 11.66±6.45 nmol/h/mg, with considerable intra- and interpatient variability (about 60%), and with no decrease in inhibition level (73.3%, range: 54.0-96.6). No significant intergroup differences were found. Mean concentrations of CsA, TAC, SRL and MPA were 142.4, 9.4, 12.9 ng/ml and 3.38 μg/ml. Four patients experienced acute rejection (AR) during the 12-month follow-up. IMPDH activity at t0 was increased during rejection versus non-rejection in 3 patients. No differences in enzyme inhibition levels were observed.
Conclusions: Despite the association found between IMPDH activity and AR, the high intrapatient variability affects its effectiveness as a predictive tool in long-term transplant outcomes. Further trials, also including pre-transplant data on both IMPDH expression and biological activity, are warranted to better assess the rule of IMPDH activity as biomarker for MPA effect in clinical practice.
Keywords: Mycophenolate Mofetil, combined therapy, Pulsed Doppler tissue imaging Dobutamine stress echocardiography
In Press
07 Mar 2024 : Original article
Long-Term Outcomes with Prolonged-Release Tacrolimus in Kidney Transplantation: A Retrospective Real-World ...Ann Transplant In Press; DOI: 10.12659/AOT.942167
07 Mar 2024 : Original article
Outcomes of Renal Transplantation in ANCA-Associated VasculitisAnn Transplant In Press; DOI: 10.12659/AOT.943433
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860